Skip to Main Content

Hello, everyone, and welcome to the middle of the week. You made it this far, so why not continue, yes? Perhaps a cup or two of stimulation is in order. Our choice today is hazelnut, an old standby. As you know, a prescription is not required. So feel free to indulge as you attack the laundry list of meetings and deadlines that await. Meanwhile, we have once again assembled a list of tidbits for you to peruse and help you on your way. Hope you have a smashing day and, as always, do drop us a line when you hear something interesting…

The U.K. government is collaborating with Moderna to build the country’s first manufacturing center for mRNA vaccines in a deal worth about $1.2 billion as it seeks to be a leader in responding to pandemics, The Financial Times writes. The government is aiming to secure homegrown supplies of the mRNA technology that has proved a crucial weapon in the fight against Covid-19 and offers the prospect of transforming treatment for other conditions such as cancer. Once built, the center will manufacture up to 250 million doses per year, including some for export. The 10-year deal, to be finalized this summer, also includes working together on research and development.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment